Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy. Mol Cancer. 2007 Jul 10; 6:46.
View in:
PubMed
subject areas
Aminoimidazole Carboxamide
AMP-Activated Protein Kinases
Antineoplastic Agents
Apoptosis
Cell Division
DNA Replication
Drug Delivery Systems
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Enzyme Activation
G1 Phase
Humans
Imidazoles
Leukemia-Lymphoma, Adult T-Cell
Multienzyme Complexes
Neoplasm Proteins
p38 Mitogen-Activated Protein Kinases
Phosphorylation
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prodrugs
Protein Processing, Post-Translational
Proto-Oncogene Proteins c-akt
Pyridines
Ribonucleotides
Sirolimus
Tubercidin
Tumor Cells, Cultured
authors with profiles
Inderjit Singh